Effect of Mediclor to protect from urethral stricture after Transurethral resection of the prostate (TURP) : Randomized, prospective, Single-blind study.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0003083

Enrollment

192

Registered

2018-08-13

Start date

2016-04-25

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1. During the transurethral resection of the prostate, use a urethral endoscope to check the length from the urethral organs to the surgical site. 2. After inserting the Foley catheter into the

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) Clinically diagnosed as benign prostatic hyperplasia and undergoing transurethral resection of the prostate (2) Subjects who are willing and able to comply with the written consent and clinical trial procedures

Exclusion criteria

Exclusion criteria: (1) Have previously history of endoscopic- or open- prostatectomy due to enlarged prostate. (2) Urethral stricture confirmed by endoscopy (3) Patients who have neurogenic bladder (4) Patients who have urinary tract infection (5) Have previously history of radical prostatectomy due to prostate cancer.

Design outcomes

Primary

Measure	Time frame
Presence or absence of urethral stricture	—

Secondary

Measure	Time frame
peak urine flow rate	—

Countries

Korea, Republic of

Contacts

Public ContactSeung Wook Lee

Hanyang University

swleepark@gmail.com+82-31-560-2372

Outcome results